Wed. 8 May 2024, 4:08pm ET
Benzinga
Earnings, Earnings Beats, News
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 41.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $14.818 million which beat the analyst consensus estimate of $14.180 million by 4.50 percent. This is a 63.63 percent increase over sales of $9.056 million the same period last year.